Friess Associates LLC Emergent Bio Solutions Inc. Transaction History

Friess Associates LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$39.92 - $53.86 $10.2 Million - $13.8 Million	-255,443 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$48.23 - $66.16 $72,441 - $99,372	-1,502 Reduced 0.58%	255,443 $12.9 Million
Q4 2018 Feb 14, 2019	BUY	$55.63 - $73.24 $14.3 Million - $18.8 Million	256,945 New	256,945 $15.2 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.